ad image

IssueQ42017

1 / 1
Segregation in the Design of Gene Therapy Manufacturing Facilities
Cell and Gene Therapy

Segregation in the Design of Gene Therapy Manufacturing Facilities

Peter Walters

CRB USA

PAP-Q4-17-CL-002Oct 31, 2017
No Clinically Meaningful Difference: The Upward Trend of Biosimilars
Regulatory

No Clinically Meaningful Difference: The Upward Trend of Biosimilars

Steve Kuehn; Cynthia A. Challener, Ph.D.; Emilie Branch; Carrie Cao, Ph.D.

Nice Insight

PAP-Q4-17-FA-001Oct 31, 2017
From Digitalization to Nanoscale Delivery: Emerging Technologies Are Driving the Future of Pharma
Nice Insight Overview

From Digitalization to Nanoscale Delivery: Emerging Technologies Are Driving the Future of Pharma

Nigel Walker

Nice Insight

PAP-Q4-17-NO-001Oct 26, 2017
Managing the Complexities of Outbound Clinical Drug Distribution
Clinical Trials

Managing the Complexities of Outbound Clinical Drug Distribution

Ariette van Strien; Wes Wheeler

Marken

PAP-Q4-17-CL-001Oct 26, 2017
Right-First-Time Innovation Approach Drives Continual Investment
API

Right-First-Time Innovation Approach Drives Continual Investment

Adam Kujath

Alcami

PAP-Q4-17-CL-003Oct 26, 2017
ADCs: The Future of Biologic Drugs
Biologics

ADCs: The Future of Biologic Drugs

Guy Tiene; Gabriel Haering, Ph.D.; Thomas Rohrer; Mark Wright, Ph.D.; Scott Miller, Ph.D.; Jean Blehaut

Nice Insight

PAP-Q04-17-VP-001Oct 26, 2017
Moving Beyond Monoclonal Antibodies
Innovation

Moving Beyond Monoclonal Antibodies

Steve Kuehn; Cynthia A. Challener, Ph.D.; Emilie Branch

Nice Insight

PAP-Q4-17-FA-002Oct 26, 2017
Pharma’s Automation Index on the Rise
Automation

Pharma’s Automation Index on the Rise

Steve Kuehn; Cynthia A. Challener, Ph.D.; Emilie Branch

Nice Insight

PAP-Q4-17-FA-003Oct 26, 2017
Developing Targeted Potassium Channel Openers for CNS-Related Therapeutics
Innovation

Developing Targeted Potassium Channel Openers for CNS-Related Therapeutics

Doug Krafte, Ph.D.; Aaron Gerlach, Ph.D.; Neil Castle, Ph.D.

Icagen

PAP-Q4-17-CL-004Oct 26, 2017
Achieving Efficient Pharmaceutical Synthesis with Process Intensification
API

Achieving Efficient Pharmaceutical Synthesis with Process Intensification

Stéphane Laurent

Servier

PAP-Q4-17-CL-003-5095Oct 26, 2017
Single-Use Operational Excellence Explained: Effective Lifecycle Management
Innovation

Single-Use Operational Excellence Explained: Effective Lifecycle Management

Ariette van Strien; Kenneth Clapp

Marken

PAP-Q4-17-CL-006Oct 26, 2017
Q: Looking forward, what technologies do you anticipate having the greatest impact in 2018?
Roundtable

Q: Looking forward, what technologies do you anticipate having the greatest impact in 2018?

Pharma's Almanac

PAP-Q4-17-RT-002-5096Oct 26, 2017
Q: What do you see as being the most innovative technologies introduced in 2017? Why were they important? What impacts did they have?
Roundtable

Q: What do you see as being the most innovative technologies introduced in 2017? Why were they important? What impacts did they have?

Pharma's Almanac

PAP-Q4-17-RT-001Oct 26, 2017
1 / 1